rs2274339

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001351169.2(NT5C2):​c.540-277A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.311 in 152,094 control chromosomes in the GnomAD database, including 7,506 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.31 ( 7506 hom., cov: 32)

Consequence

NT5C2
NM_001351169.2 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.617

Publications

7 publications found
Variant links:
Genes affected
NT5C2 (HGNC:8022): (5'-nucleotidase, cytosolic II) This gene encodes a hydrolase that serves as an important role in cellular purine metabolism by acting primarily on inosine 5'-monophosphate and other purine nucleotides. [provided by RefSeq, Oct 2011]
NT5C2 Gene-Disease associations (from GenCC):
  • complex hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 45
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001351169.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 10-103100296-T-A is Benign according to our data. Variant chr10-103100296-T-A is described in ClinVar as Benign. ClinVar VariationId is 667538.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001351169.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NT5C2
NM_001351169.2
MANE Select
c.540-277A>T
intron
N/ANP_001338098.1P49902-1
NT5C2
NM_001351170.2
c.564-277A>T
intron
N/ANP_001338099.1A0A6Q8PHP0
NT5C2
NM_001351171.2
c.564-277A>T
intron
N/ANP_001338100.1A0A6Q8PHP0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NT5C2
ENST00000404739.8
TSL:1 MANE Select
c.540-277A>T
intron
N/AENSP00000383960.3P49902-1
NT5C2
ENST00000343289.9
TSL:1
c.540-277A>T
intron
N/AENSP00000339479.5P49902-1
NT5C2
ENST00000874311.1
c.756-277A>T
intron
N/AENSP00000544370.1

Frequencies

GnomAD3 genomes
AF:
0.311
AC:
47329
AN:
151976
Hom.:
7500
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.328
Gnomad AMI
AF:
0.332
Gnomad AMR
AF:
0.264
Gnomad ASJ
AF:
0.361
Gnomad EAS
AF:
0.209
Gnomad SAS
AF:
0.245
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.325
Gnomad OTH
AF:
0.314
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.311
AC:
47360
AN:
152094
Hom.:
7506
Cov.:
32
AF XY:
0.307
AC XY:
22831
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.328
AC:
13609
AN:
41478
American (AMR)
AF:
0.264
AC:
4034
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1253
AN:
3472
East Asian (EAS)
AF:
0.208
AC:
1080
AN:
5188
South Asian (SAS)
AF:
0.245
AC:
1179
AN:
4822
European-Finnish (FIN)
AF:
0.289
AC:
3057
AN:
10562
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.325
AC:
22076
AN:
67966
Other (OTH)
AF:
0.313
AC:
662
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1712
3425
5137
6850
8562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.330
Hom.:
1039
Bravo
AF:
0.310
Asia WGS
AF:
0.226
AC:
785
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.14
DANN
Benign
0.51
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2274339;
hg19: chr10-104860053;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.